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TREATMENT OF THE HOSPITALIZED
MENTALLY ILL
By

HARRY

c. SoLOMON, M .D.

is an exhilarating and exciting period for those of us who are
T HISconcerned
with treat ng the overtly ill mental patient, especially
those afflicted with major psychoses. The reason for the exhilaration
arises out of the fact that our efforts are meeting with a degree of success
which could hardly have been contemplated two decades ago. To those
of us who have been in the work for two or more decades the change in
the results obtained with patients in this category is only equalled by the
change in attitude of the younger physicians entering into the treatment
of th e mentally ill. In our institution, if a patient no matter what his
diagnosis, does not show distinct improvement in the course of days or a
few weeks, the physician in charge of the case is disturbed and distressed
and feels that he has somehow failed to offer the proper treatment. It is
refreshing to find that the physician's questions are concentrated on the
treatment. Diagnosis to be sure is important, not as the end of the road
but rather as an indication of whether the treatment has been the proper
one for a patient with a certain constellation of symptoms. This change in
the medical attitude is unquestionably brought about from the fact that
patients are being helped, that in a large majority of severe acute mental
illness the expectation is for improvement of a degree sufficient for the
patient to leave the hospital within a relatively short time and to take up
his activities in the community as effectively as, or better than, before the
illness.
In order to substantiate the statements about the high improvement
rate I would ask your forbearance while I present to you the results of
treatment at the Boston Psychopathic Hospital for one year. The year
chosen is our statistical period of July 1, 1946 to June 30, 1947. This year
is p icked because it represents pretty accurately the situation as it exists
today and, a period of 18 months having expired since the end of this
p eriod, there has been an opportunity to learn something of what happened to the patients. The statistical findings for the previous year,
1945-46, are very nearly identical, supporting the significance of these
results.
T he Boston Psychopathic Hospital is a small psychiatric clinic maintained by the Commonwealth of Massachusetts as part of its state hospital
D r. Solomon is professor of Psychiatry at H arvard Medical School and D irector of the
Boston Psychopathic Hospital. This paper was delivered at the 4th B. T. M cGhie
Memorial lectureship

89

90

UNIVERSITY OF WESTERN ONTARIO MEDICAL }OURNAL

system, with a licensed bed capacity for 117 patients. Patients are admitted to the institution from any portion of the Commonwealth, but
chiefly from the Boston metropolitan district. Patients of the old age
group are not admitted. Otherwise any mentally ill patient requiring
hospitalization is welcomed. There is usually a greater demand for admissions than can readily be handled, so a waiting list is usually in existence.
Acute emergencies are of course given precedence and almost always
accepted if the need is sufficiently great. Patients are admitted from the
community almost exclusively either on a temporary care paper from a
practising physician or on a voluntary basis. Another group of .patients
are transferred from other state hospitals for special diagnostic procedures or special treatment, particularly psychosurgery and treatment of
central nervous system syphilis. In addition, a considerable number of
individuals are sent to the hospital for psychiatric survey and study by the
courts in the district near the hospital. This group, which represents a
high percentage of admissions, come in for short study and occupy about
10 percent of the bed capacity of the hospital, the other 90 percent being
used more specifically for therapeutic purposes. During the year under
consideration 440 patients were admitted from the community on a doctor's certificate, of whom 36 or 8 percent were committed elsewhere, and
an additional 118 patients were admitted voluntarily, of whom 1 was
committed to .another hospital.
It therefore appears that of the acute problems which came to our
doors, approximately 90 percent remained for treatment. Of these 558
patients, 79 percent were returned home from the hospital with an average stay of 45 days. The remaining 21 percent were sent to larger institutions of the state hospital system. The reason for the transfer in each
instance was that it was concluded that further intensive treatment was
not indicated and that either the patient was for the moment considered
as heading toward chronicity, for which no immediately applicable therapy
was advised, or that he needed a convalescent period rather than intensive and definitive treatment.
It is pleasing to report that of the group who were transferred to
other institutions, 48 percent improved sufficiently to be returned home
after some months of care.
The immediate outcome therefore indicates that ·89 percent of the
patients admitted to the hospital for treatment during the period under
consideration improved sufficiently to return to their community activities.
May I emphasize the 89 per cent figure? Of the remaining 11 percent of
the to~al patients admitted for treatment, some go on to chronicity and
some of them improve in the course of several years. Of course the number who will get well after two or more years of illness is very small.
However, for the patients who fall into the chronic classification, some
form of psychosurgery is still available and, as will be indicated shortly,
with the expectation of some good results. It may be added at this point
that there will certainly be some relapses among the 89 percent who have
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done well. Among the cases that relapse, some will have brief illnesses
with recovery, some occasional severe illnesses, and some others will fall
into the chronic category, and again fo r them psychosurgery will be available to benefit a fair percentage.
It is on the basis of these results with the acutely ill patients that I
believe enthusiasm for modern therapy can be justified.
It is now in order to attempt to describe what is meant by the present
day psychiatric therapy. All therapy must of course stem from careful
diagnostic study of the individual to be treated . Such study includes a
good general physical and neurological examination of the patient, with
all the aids that general medicine has at its command which, in certain
cases, would include rather special neurological studies such as electroencephalography and airencephalography. It includes in addition a careful psychiatric analysis of the case, with the assistance of the available
batteries of psychological tests, and interviews aided by such drugs as
sodium amytal, sodium pentathol and pervitin.
From the therapeutic standpoint psychiatry has at its service today a
number of procedures and aids which can be briefly summarized in two
groups, the first of which I will call the definitive psychiatric therapies
and the second the general and socializing therapies.
Definitive Psychiatf'ic Thef'apies
Genef'al and Socializing The,.apies
Psychotherapy
Psychiatric Nursing
Occupational Therapy
· (a) Individual
Psychiatric Social Service
(b) Group
Recreation
Convulsive Shock
Insulin Shock
Physio and Hydrotherapy
General Environment
Lobotomy
Penicillin and Fever
These are the therapeutic processes that are responsible for the beneficial results I have mentioned. Until some 15 years ago our treatment
procedur-es were limited to individual psychotherapy and the general and
socializing therapies. In recent years the addition of the other so-called
somati' therapies has aided a great deal toward a favorable prognosis.
At the same time psychotherapy has become more effective and our general therapeutic processes have been improved. It is not possible to give
a cleat depiction of what each of our treatment procedures has added to
the general over-all recovery and improvement rate of patients because
each has unquestionably added its share, but some general ideas of ~alues
of some of the procedures may be considered.
Convulsive shock therapy has been a very effective therapeutic tool
for a great many patients. Approximately 90 percent of the patients in
the manic-depressive group treated by convulsive therapy are returned to
a good mental status in a matter of days or weeks. The course of an
attack is telescoped. Many patients in the schizophrenic groups are also
impro·red sufficiently to lead comfortable community lives in relatively
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short period. Of 157 patients at the Boston Psychopathic Hospital whose
only specific therapy was electric convulsive, 83 percent recovered sufficiently to return to their homes. This included patients whose symptom
constellation placed them in several diagnostic groups.
At the Westchester Division of the New York Hospital Drs. Hamilton and Wall made a very careful study of 100 consecutive female admissions with a diagrosis of schizophrenia who were treated by short courses
of convulsive shock, and reported that 67 percent made a reasonably
prompt recovery. This was approximately twice as great a recovery rate
as had been obtained in a previous period at the same hospital with essentially similar treatment aside from the convulsiv~ therapy.
This type of therapy also has an amazing therapeutic value in cases
of the involutional psychoses in which group the psychoses may be shortened by months or years, in contrast to cases that do not receive this type
of treatment.
Probably the most spectacular effect of this type of treatment is
obtained in cases of acute confusion and excitement. Such cases which in
a few instances without this treatment go on to death, the so-called Bell's
Mania, can be brought to a state of reasonable social behavior in a matter
of days, and the jeopardy of death in the excitement is eliminated. The
alleviation of excitements of almost all varieties, even when due to
organic disease of the brain, can be usually accomplished very quickly.
This obviates many grave dangers to the welfare of the patient and at the
same time produces a condition in the wards that allows for better treatment of all the patients.
_Perhaps a brief account from a nurse's report of the care of one
patient will illustrate these latter points.
A 23-year-old woman was admitted to the hospital nine days after
delivery of a daughter. She was tense, apprehensive and irritable. She
was disoriented and misidentified people. She was in a state of great
turmoil, was impulsive and was responding to auditory and visual hallucinations. She believed that someone had taken her baby from her and that
her husband was unfaithful to her. She responded in an aggressive manner to the voice of a doctor by whom she had previously been treated. At
times she was combative, assaultive and would explain her violence by
saying "Dr. C. told me to do it." She would not keep any clothes on and
any attempt made by the nu rses to ke'!p her clothed was met by aggressive
action on her part.
·o n admission she showed signs of sepsis; her temperature reachel
102°; she became jaundiced, her breasts were engorged, she was
dehydrated and, because of her restiveness, it was difficult to m3.intain an
adequate fluid level.
After three electric shock treatments a remarkable change in her
mental state became apparent. She became co-operative, well oriented
and free of hallucinosis. Her general physical condition improved
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markedly; she ate normally. In less than three weeks she was relatively
well and able to go home for a week-end visit. The nursing problem,
which for the first three days before shock was administered was
extremely dificult and far from adequate in its results, became simple and
effective.
Convulsive shock treatment offers an opportunity for the alleviation
of distressing symptoms, followin g which a better relationship may be
established between patient and staff than can be obtained without this
means. Regulation of a patient's sleep is part of the effects as is the lack
of feeding difficulties. With proper sleep and nourishment, with reasonably good social contacts, treatment procedures may be carried out which
under other circumstances would be quite impossible. Undoubtedly this
whole group of circumstances affords a better opportunity for the recovery potentials of the individual to make themselves felt.
Insulin shock therapy in our hands has been reserved largely for
those patients who have failed to respond to general care and convulsive
therapy and for whom it is believed that psychotherapy alone is not adequate. In the case of certain schizophrenics insulin therapy is introduced
early in the treatment prog ram without th e use of convulsive shock, but
by and large in our cases convulsive therapy is first tried and if found
ineffective insulin is given.
In the year under consideration 51 cases were given insulin coma
therapy ; 37, o r 73 percent, improved sufficiently to be discharged home.
When it is recalled that most of th ese patients were unsuccessfully treated
before they were given isulin , th e value of this treatment is apparent.
There are relativel y few well controlled series of patients treated with
insulin in comparison with untreated cases. However, where it has been
done, notably the Brooklyn State Hospital g roup, the evidence was strong
on the point of the value of this ty pe of treatment.
During the course of insulin coma t reatment one is impressed by
several observations. The patients in general thrive physically, they put
on weight, they look well and they sleep well. Perhaps even more important, most of the patients become friendly and readily develop a warm
relationship with the staff. Personall y, I am continuously amazed that
most patients receiving insulin coma treatment put up no resistance
thereto but,on the contrary, seem to take pride in being a member of the
treatment g roup. They feel , apparen tly, that they are especially distinguished thereby. All of this is impo rtant and helpful to the patient and
probably in itself plays a role in the road toward improvement.
Psychotherapy in the genera l care of patients is of great importance.
Psychotherapy in the course of the years has found itself in relation to the
treatment of the psychoses. It is not the intent of this discourse to discuss
the details of techniques. Suffice it to say that as our understanding of
psychological dynamics has become g reater, more definitive psychological
treatment is available. In most cases the use of individual and group
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psychotherapy is part of the total treatment program, and in a great many
cases psychotherapy and general care represent the major if not the total
program.
The decision as to what form of treatment to use and when to app!y
various methods is a matter that needs fine judgment. As in all treatment
procedures, discrimination and judgment on the part of the physician
directing the program is the first requisite. That judgment is not always
perfect follows from the fact that medicine is still an art. The results of
treatment of psychotic patients will vary according to the wisdom and
ability of the physician as well as to the intrinsic capacity of the patient
for recovery and the value of the therapeutic methods. Improperly chosen
methods or the application of a method at the wrong period may be
harmful rather than beneficial, and continuous study of our techniques
is necessary. It will be long before we are able to offer a systematic
formula which he who reads may utilize successfully.
It is my firm belief that the general and socializing therapies of the
hospital should play a very heavy role in the total treatment program, and
I have no doubt that the effectiveness of the treatments mentioned is
dependent upon the skill and excellence of the 24-hour-a-day care of the
patients. The conditions under which any individual lives greatly influence his reactions and behavior. If war experiences taught us anything,
they taught us that emotional stress could cause grave damage to humans.
They taught us that general morale was essential for adequate behavior.
The same is true of the mentally ill patient in a hospital. If conditions
are adverse it is hardly to be expected that the patient will flourish and
improve. Catatonic syndrome is in many instances merely an expression
of intense fear on the part of the patient who feels himself separated
from human relationships and thus tries to hide within his own skin. If
such an individual is met with aggressive behavior on the part of those
who are looking after him, if he feels coldness in the emotional atmosphere, if his fear is increased by harsh words and restrictive and suppressive measures, he either retreats further into himself or becomes
assaultive. Skillful treatment in the early period of hospitalization by the
nursing staff is probably more important than the doctors' skills. It is
our experience at the present time that the so-called catatonic retreat
rarely lasts more than 24 to 48 hours; kindly understanding, sympathy
and attention on the part of the nursing staff almost invariably lead to
overcoming mutism anq refusal of food. With good nursing and with
the proper utilization of the specific psychiatric therapies, the acute wards
of the hospital become not unpleasant places in which to be. Where
aggressive and assaultive behavjor is at a minimum, where the ward is
quiet and the patients not too disturbing to others, a better chance for
recovery exists than where tempestuous and distressing behavior predominate. In the ward where the patients are well behaved attention can
be given to esthetics and this I believe has a very beneficent effect. The
use of pleasing colors on the wards, an occasional picture, attractive bed-
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spreads, drapes on the windows, comfortable chairs and a spirit of friendliness in the ward are extremely important details in the care of the
patients.
The hospital allows no form of restraint except post-operatively
when a patient's hands may of necessity be restrained to keep him from
removing bandages and infecting a wound. No "legitimatized" restraint
such as packs or prolonged baths are used nor is chemical restraint, in
the form of sedative drugs to quiet a patient, permitted.
With the elimination of restrictive methods, the need of seclusion
drops to a minimum. To be sure, occasionally a patient who becomes a
little disturbing to others may have to be temporarily isolated, but this is
rarely for more than an hour or two at a time.
The nurses and attendants in this circumstance become important
members of the therapeutic team. Upon their shoulders rests the responsibility of seeing that the patient has the proper environment in which to
live a somewhat reasonable existence. The nurses and attendants are
challenged to use no force, to win the confidence of the patients through
understanding their behavior and the factors that motivate them. This
requires not only extreme skill but much understanding forbearance. ·
Perhaps a picture of the nursing problem can be best presented by a
quotation from the nurses' notes concerning the patient briefly mentioned
above.
Feeding problem: On admission Phyllis had many _p aranoid tendencies, so therefore she refused food , accusing us of putting something in
it. With much patient persuasion she would drink a glass of milk, eggnog or eat some food . However, she was very unpredictable and just
when we had become quite confident in her she would throw the milk at
us or pour it on the floor and play with it.
"Under the influence of sodium amytal she was fed , bathed, clothed,
mouth care was given and blood was taken for examination.
"Elimination: She defecated and urinated on the floor several times
a day. More frequent toile~ing helped this somewhat. She was changed
from one seclusion room to another to keep her as clean as possible.
Probably due to her overactivity, there was still more lochial discharge.
She masturbated at times and when spoken to would say, 'I shouldn't do
that, should I?'
"Fersonal hygiene: Her lips were cracked and dry due to her overactivity, refusal of fluids and elevated .temperature. Her t~eth became
coated and her tongue parched and dry. Ointments were applied to her
lips and, under sodium amytal, mouth care given. This didn't seem to
have too much effect on her broken, bleeding mucous membranes.
"As she was denudative it was difficult to attain bodily cleanliness as
she would lie on the bare floor, ignoring the mattress, refusing any type
of clothing, even slippers on her feet. She also played in feces , covering
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the walls with it. When placed in the bathtub, Phyllis seemed to have no
regard for her surroundings and splashed freely, succeeding in getting
the floor and screens all wet.
"Her body was badly bruised, especially her legs, arm~ and the back
of her neck. Her bed had been removed from the room to prevent any
further injury to herself SQ that only the mattress and blanket remained.
as she destroyed sheets, etc., if given to her.
"Her door was locked to prevent disturbing the other patients. She
was unpredictable and became assaultive to nurses who would try to feed
her or care for her in any way. At times she would hug another nurse
and express homosexual desires. Being denudative was also an important
reason for placing her in seclusion.
"As far as relationship with patients and personnel was concerned.
Phyllis had her own companions with her visual and auditory hallucinations. She would stand in a catatonic-like position, look at the light, seeing the 'twinkle' in Mac's left eye also saw this in other people's eyes.
She would wink and laugh inappropriately in response to many things
said to her.
· "There was a definite problem in keeping the breast binder on, prescribed because of engorged breasts, although she said they didn't pain
her. Pins, of course, couldn't be used, therefore wide tape was substituted. She would only keep this on for a _short period of time.
" Now that most of these previous problems have subsided , the present problem is that of keeping her active."
Now that Phyllis is well she is most grateful to the nurses whom she
so badly tormented, and they are more than pleased with the effectiveness
of their contribution to her recovery. The last sentence of the notes above
CjUOted states that the present problem is to keep her active and here is
where the matter of occupational therapy and recreational facilities come
m. It is with the acutely ill patient that occupation and recreation are
most needed. I fear that too fre<:juently these procedures are afforded
patients who are already well enough to take advantage of them. Our
efforts are now directed toward giving the maximum in occupation and
recreation to the patients who are too ill and too poorly socialized to go
to an occupational therapy room. It is in the acute ward that the occupational therapist and the recreationalist can perhaps offer the greatest
benefit. As the patient improves in his general behavior and socializing
possibilities he can gain more freedom of action and have perhaps a
g reater scope for his abilities, but it is in the early and acute stage of his
illness that special study by the occupational therapist probably pays the
g reatest dividends.
As one learns more and more of the internal mechanisms of the
patient one learns more concerning fear and apprehension and anxiety on
the one hand and resentment, sense of frustration and objection to being
bos ed. The elimination of factors leading to such viewpoints is an
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essential feature of general psychiatric treatment. As far as is consistent
with the welfare of others, the patients are allowed to express themselves.
The patients on our more convalescent wards have a self-governing
committee composed of men and women patients who make their own
rules and regulations, assign tasks and police the wards. If 9 hours are
given over to sleep, there remain 15 hours to be occupied in some fashion
by the patient. If left to themselves they soon slump into a state of inertia
or destructive activity or retreat into ruminating and hallucinating
phantasies.
It is rarely possible for a hospital to have a staff sufficiently large to
give the necessary individual and group attention to patients. Therefore
assistance must be obtained from various sources. The development of
initiative and responsibility on the part of the patient is important. Students working and learning at the hospital add a good deal to the interest
and color ·of the daily life of the patient. Volunteers of many varieties
can add greatly to the interest of a patient's day. Many, if not most
mentally ill patients have great difficulty in inter-personal relations.
Many are shy, most feel out of touch with other persons. The socializing
efforts which can be applied become valuable therapies. In our hospital,
in addition to the attention given patients by students of several
disciplines such as psychologists, sociologists, psychiatric social workers,
nurses and clerics, much satisfactory work is done by volunteers.
Perhaps a good viewpoint to hold is that if a patient is unfortunate
enough to be so ill as to need treatment in a mental hospital, his stay
should be utilized to give him new outlets, new interests and perhaps new
skills. He should have some things in his repertory of capacities over and
above what he had when he entered the hospital. A dancing class has
been found to afford the patient great interest; similarly cooking and
candy-making, hat-making and dress-making offer the development of
skills that have value to the patient on leaving the hospital.
During the year under consideration 166 patients were subjected to
the lobotomy operation. The patients who received this type of treatment
were selected on the basis of a long period of mental illness with the conclusion having been reached that the probability of recovery through any
other form of treatment was extremely small. Of this group of 166
patients, 75 ( 45 % ) returned to their homes with some degree of improvement. The majority of these patients were in the chronic stage of schizophrenic psychosis, namely 123 out of the 166. The results in these patients
were approximately the same from a percentage standpoint as for the
total group.
The greater majority of the patients who were subjected to the operative procedure were sent to the Boston Psychopathic Hospital from the
larger hospitals of the state hospital system. The group was made up of
patients many of whom had been in hospital for a great number of years
and who were extremely disturbed distressed and distraught. A smaller
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portion of the patients had been ill or hospitalized a much shorter period
of time, in the neighborhood of two years, and had very intensive treatment in the present mode but had failed to respond satisfactorily. There
were 47 such patients operated upon of whom 37 or 97 percent were able
to return to community living. This is in considerable contrast to the
group that have been sent to us after a long hospital stay, of whom only
26 or 24 percent of 105 patients were sufficiently improved to allow them
to go home. This result is consistent with the experience of others as
well as ourselves, namely that a greater degree of success from psychosurgery is to be expected in patients who have not been ill too long.
I would emphasize that of the type of patients who seek service in
an acute hospital installation such as ours and who come to psychosurgery
because of failure of our other forms of treatment, a distinct improvement can be expected in well over 50 percent. It is our procedure.in many
cases to give the patient the treatment which we are able to offer at the
time of admission and, if improvement does not occur, the patient, unless
he has been ill for a considerable period of time before admission, is sent
to a larger hospital with chronic facilities with the idea that if, in the
course of a year or 18 months, improvement has not resulted, he will be
returned to us for psychosurgery.
Let us review then what our experience indicates as the fate of the
type of patient who enters our hospital as a more or less acute mentally
ill individual. On the basis of treatment which we have availaible and
which we have already discussed, it is seen that nearly 80 percent will be
returned home in an improved state ditectly from our institution, that
some 20 percent will be sent to other mental hospitals for more prolonged
care and that of these approximately one-half will make a sufficient
improvement to return to their homes within 18 months. This accounts
for almost 90 percent of the patients. Of the remaining 10 or 11 percent
who have failed to recover and may be considered as chronically ill, a
considerable number will be good subjects for psychosurgical intervention, and of those who receive such treatment more than 50 percent will
be benefitted sufficiently to be out of the hospital. One arrives at the
astounding if not phantastic figure of well over 90 percent of the patients
entering a hospital such as ours being returned to the community.
I have carefully avoided the use of the word "cured" or "recovered,"
not because I think that the term is not applicable but because there is
such a strong sentiment or prejudice in the minds of most people, psychiatrists, psychologists and nurses, as well as the layman, to talking about
recovery of the mentally ill. The question always is asked, "But do the
patients remain well? Don"t they relapse?" Indeed this is a proper question as it is in the case of cancer or heart disease or perhaps pneumonia.
Some of the patients about whom I have given these statistics relapse
or have another attack of mental illness. Indeed this is characteristic of
patients who have a manic-depressive psychosis and it is true for a con-
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siderable number who are diagnosed as having schizophrenia. Unfortunately I am not able at this moment to furnish accurate statistics about
recurrence of mental illness in the patients of our group. Such a study is
being conducted but is not far enough advanced to be discussed. The
number who break down within a one, two or three year period, however,
is not great. Those who do have a recurrence or a new attack are usually
treatable again and the results of the treatment of the new attack are on
the whole rather similar to what has been described above. A certain
percentage do fail to recover from a second, third or subsequent attack of
mental illness and become chronic. These patients again form a group
for whom psychosurgery offers great advantage. It is from this group
that perhaps the best results of operative intervention are to be expected.
I would belabor the point that too much pessimism exists about recurrence of mental disorders in individuals who have once been afflicted and
would emphasize the point that there is not as great a danger as is often
believed, but I would emphasize more especially that recurrence may be
of very short duration and the outcome excellent. I would point out that
the period of disability in many of the patients in our group is relativ~ly
short- ten, twenty, thirty, forty or fifty days.
Another tendency in thinking of mental disorder which has had a
deleterious, almost paralyzing effect, is to be overly concerned as to
whether recovery occurs without any defect. In hardly any other field of
medicine does one expect complete restoration.
It has been stated in the course of these remarks that general care
and psychotherapy are utilized and relied upon either as a total or certainly as an associated treatment procedure in most cases. Treatment does
not necessarily cease when the patient leaves the hospital--on the contrary it is after returning home that most intensive work is often necessary. Many of our patients continue treatment for weeks or months as
out-patients. Prior to as well as after the return home it is often important
that much work be accomplished with the families of patients, and in this
sphere of endeavor the psychiatric social workers have a big stake.
As we scrutinize the results of our experience in the treatment of
patients with acute mental illness we come to the conclusion that the
opening statement of these remarks is correct, that it is indeed a period in
which we have reason for hope and a considerable amount of satisfaction.
There are many, many things still to be accomplished. However, with the
methodology at hand, it would appear that a concentrated therapeutic
attack upon the early stages of a patient's illness brings worthwhile
results. General Eisenhower in his book " Crusade in Europe" stressed
that in the campaign it would have been more costly to set up a perfect
line of defense and sit tight than to continue a vigorous offensive. Similarly an intensified offense toward early treatment of the mentally ill
would seem to be infinitely more effective than preparations for prolonged care of patients who have not been given the utmost at the period
of onset of the illness.

ADVANCES IN GASTRIC SURGERY
By RAYMOND W. McNEALY, M.D.

T

HE advances in gastric surgery have been of an evolutionary type.
On the whole, they have developed along lines which have had their
foundations in mechanical rearrangements of the viscera with a view of
eliminating the pathology, at the same time preserving a gastro-intestinal
continuity.
Gastric resections were performed successfully as early as 1879. The
first resection was done for carcinoma involving the pyloric end of the
stomach. It is very interesting that gastric resections were done before
the technique of gastro-enterostomy was developed. The first gastroenterostomy was done by WoHler in 1881. It was performed for an
unresectable carcinoma of the pyloric end of the stomach. The first
gastro-enterostomy for a benign ulcer of the duodenum with pyloric
stenosis was done in 1884.
The operation of gastro-enterostomy was popularized in the United
States following a visit in 1902 of Sir Berkley Moynihan. This operation
gamed great favor in the treatment of peptic ulcer and its complications.
It was revealed by careful follow-up of these gastro-enterostomy patients
that stomal and jejunal ulcers were serious complications in more than 25
per cent. About 1927 Finsterer and other continental European surgeons
stressed the value of partial gastric resection for peptic ulcers that were
unsuited to medical management.
Even partial gastrectomy left much to be desired, for some of these
patients developed stomal and jejunal ulcers.
Vagotomy has been suggested as a means of lowering the acidpepsin factor which is generally conceded to be the perpetuating influence of ulcers in the upper gastro-intestinal tract. The thoracic approach
to the vagus nerves afforded the most reliable method for exposure and
complete division of these structures. This exposure, however, had the
disadvantage of allowing no exploration of the stomach and duodenum
or of the other viscera in the abdominal cavity. The abdominal approach
had the advantage of permitting exposure and examination of the viscera
but the dissection and complete division of both vagi and all their
branches were far more difficult. There was a further complication that
developed in those whose nerves were severed. They developed motor
deficiencies which were followed by poor emptying and gastric dilatation.
Gastro-enterostomy or partial resection seemed necessary as a supplementary measure to vagotomy.
There have been several very dependable studies made on these
patients with vagotomy. The final evaluation of this procedure cannot
Dr. McNealy is professor of surgery at Cook County Graduate School of Medicine and
president of the staff of Cook County Hospital. This paper was delivered at the
annual Academy Day Program of the London Academy of Medicine.
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be made at this time. The operations have not been of one type in enough
cases to permit one to draw conclusions as to the merit of this type of
surgery.
We have had very few successes in surgery which were the result of
mechanical interventions in physiological activities of the body. Our
resection of the major portion of hypersecreting goiters has been the most
outstanding. Resections of other hypersecreting endocrines have also
been successful but they are not so numerous as to give great encouragement to less direct invasions of the field of unbalanced physiology.
Our advances in gastric surgery in 70 years leaves much to be
desired. There is much to be done.

NEW DRUG ON PRESCRIPTION ONLY
Ottawa, Feb. 28.- Hon. Paul Martin , Minister of National Health and Welfare, announced to day that it had been found necessary to add to the list of
drugs to be sold only on prescription, Tetraethylthiuram disulphide, commonly
known as Antabuse or Abstinyl.
He pointed out that this drug, which is very potent, will be available on the
Canadian market almost at once, and that, in view of its effects, had to be
restricted as to sale.

A STIJDY OF THE ADRENERGIC BLOCKING
AGENT, DIBENAMINE
- (N,N-dibenzyl-beta-chloroethylamine)
By MARloN G. MARsHALL
History
amine~

chemical is a member of a series of tertiary
whjch have
T IllS
recently been found to possess considerable power and specificity as
adrenergic blocking agents, both in animals and in man (9, 10, 13, 23).
First of the series to be discovered, and described by 0. Eisleb in 1930,
was Dibenamine. The original synthesis of this drug in North America .
was by Dr. W. Gump of Givaudan-Delawanna, Inc. of New York. This
chemist has subsequently prepared a number of the congeners and related
compounds of Dibenamme.
The pharmacology of Dibenamine was first studied by Nickerson
and Goodman of the Unjversity of Utah School of Medicine. They
reported at a meeting of the American Federation for Clinical Research
in March, 1946 (15), and later in the literature (14), a large number of
experiments on animals and a more limited number on man. The detajled
pharmacology with regard to man was studied by Hecht and Anderson in
the Department of Medicine of the University of Utah. Since that time
Givaudan-Delawanna has supplied the drug to a number of other laboratory and clillical workers for investigational use. The distribution for
clillical studies is now in the hands of Smith, K;line, and French laboratories, Philadelphia.
Chemistry
The chemicals of the series of which Dibenamme is at present of
greatest interest, and thus here considered as the prototype, are betachloroethylamines. At least one chlorine and one benzyl group was found
to be necessary for activity of the series (7). The series is chemically
related to the nitrogen mustards (bis- and tris-chloroethylarnines).
Although Dibenamine does not have the second beta-chloroethyl
grouping of the nitrogen mustards, it exhibits many of their characteristic
chemical reactions. This fact affords a clue to the possible type of chemical union between Dibenamine and the adrenergic receptor substance.
Nickerson believes that such a chemical union does take place (16) -and is
responsible for the action of the drug; at present further investigations
along this line are being carried out ( 13). Since it is known that nitrogen
mustards owe their pharmacological activity to an intra-molecular ring
formation with liberation of chlorine, a similar mode of action has been
.
proposed for Dibenamine (7).
It is believed by Nickerson (13) that Dibenamine m aqueous solution may undergo intramolecular rearrangement to form a cyclic ethylenimonium cation. Dibenamine presumably exerts its pharmacodynamic
effects through this intermediate product, for ethylenimoruum cations are
known to have great chemical activity.
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In aqueous solutions at normal body pH, Dibenamine after cyclizing
reacts with water to form the alcohol, N - N - dibenzyl ethanolamine
which is inactive as an adrenergic blocking agent.
Physical Properties and Administration
Most of the investigators of Dibenamine have ma~e use of the hydrochloride salt, because it is more easily handled than the free base which is
an oily liquid. There is, however, no real difference in the activity of the
compound or any of its salts with organic or inorganic acids (13).
The hydrochloride is a white crystalline substance almost insoluble
in water near neutrality but soluble in aqueous acid solution of 957o
.ethanol, and in propylene glycol. The present distributors of the drug
supp,ly ampules for intravenous administration as a 57o solution in
alcohol-propylene glycol, acidified for stability . .
Dibenamine produces its systemic effects when given orally, intravenously, subcutaneously, or intraperitoneally. However, it can be
administered in man only by the first two routes.
Pharmacodynamics
The systemic effects of Dibenamine, when administered in the proper
manner and in physiological dosage, an: of a single type: blockage of all
excitatory adrenergic functions . Not only are epinephrine and circulating
sympathin rendered ineffective but also, by a slightly larger dosage of the
drug, direct or reflex stimulation of the sympathetic nerves.
Dibenamine does not affect inhibitory adrenergic functions, in fact it
often unmasks these, by removal of the excitatory elements of res.ponse,
to produce rather remarkable effects.
I. Actions on the Cardiovascular System
1. (a) Normal Laboratory Animals
Dibenamine administered slowly in full blocking doses produces no significant changes in blood pressure, basal hea.r t rate,
cardiac output, or electrocardiogram (13) .
(b) Resting, Non-hypertensive Human Subjects
The effects of Dibenamine are similar to those in laboratory
animals. However, when these human subjects rise from a supine
position there occurs a marked orthostatic hypotension, which is
maximal in 6 hours and lasts 1 to 2 days or longer (7). This
temporary hypotension is apparently due to the pooling of venous
blood in the extremities because Dibenamine abolishes reflex
postural sympathetic vasoconstriction. The recovery then is seemingly due to the adjustment of vascular muscle to maintain blood
pressure in the absence of sympathetic nerve impulses as after
sympathectomy.
2. Adrenolytic Action
(a) In Animals
In epinephrine-treated animals, Dibenamine not only blocks,
but actually reverses the pressor response. This response is true
for all doses of epinephrine investigated ( o.1 microgram to 10
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mg.jkg.) (14). Only the excitatory (vasa-constricting) act1v1ty
of epinephrine is blocked and the fall in blood pressure is therefore due to the unrestrained effect of the concurrent inhibitory
( vasodilating) activity of epinephrine. This is illustrated by the
fact that t]le fall in blood pressure with a massive dose of epinephrine lasts only until the concentration of circulating epinephrine
has fallen below the value necessary to produce vasodilation.
Another proof of this strange fact is that in the rabbit which,
unlike most laboratory animals, does not have an adrenergic vasadilating system, D ibenamine prevents an epinephrine-induced
pressor effect but does not reverse it (13).
The chronotropic and positive inotropic effects of epinephrine
on the heart are not, in animals, changed by Dibenamine (1 , 13) ,
and sinus rate, stroke volume, and cardiac output are increased as
usual. Nickerson believes the explanation for this seeming contradiction to the adrenolytic action of Dibenamine to be the existence of a basic difference in the effect of epinephrine on the sinoauricular node and on the force of myocardial contraction from
its effect on vascular smooth muscle.
The ability of epinephrine to evoke ventricular arrythmias in
animals under cyclopropane anesthesia is prevented almost absolutely by Dibenamine, although in Nickerson's study (13, 14) by
a larger dose than is required to reverse the pressor effect of the
same dose of epinephrine. NiFkerson reports an experiment with
dogs in which the controls, unprotected by Dibenamine, developed ventricular extrasystoles . multiple focus tachycardia, andj or
ventricular fibrillation. Those receiving Dibenarnine 30 minutes
previously developed only sinus tachycardia with the very occasional extrasystole. In other experiments up to 500 times the 10
microgram dose of epinephrine was administered after Dibenarnine injection without the development of any serious ventricular
arrhythmias. Since sinus tachycardia always appears in spite of
Dibenamine, this is probal!lly produced by a different action of
epinephrine than that which provokes arrhythmia.
Garb and Chenoweth (3) report -slightly different findings
from those reported by Nickerson. They note that ventricular
fibrillation can be caused by the interaction of any hydrocarbon
and any sympathomimetic amine and that Dibenamine is as effective against this arrhythmia as that caused by the combination of
cyclopropane and epinephrine. Their experiments also demonstrated the fact that Dibenamine is an efficient protecting agent
against ventricular fibrillation even in very small doses (3
mgmjkgm) which do not reverse the hemodynamic effects of
epinephrine. This is seemingly contrary to the opinion of Moe
et al. (12) who state Dibenamine " prevents ventricular rhythms
because it prevents the pressor response to epinephrine." However.
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Garb and Chenoweth found that, although ventricular fibrillation
was prevented by these very small doses of Dibenamine, heterotopic rhythms developed as frequently as in experiments without
Dibenamine. They believe, therefore, that the antifibrillatory
effectiveness of Dibenamine in doses too small to reverse the
pressor effects of epinephrine is related to the quinidine-like
action of Dibenamine described by Acheson ( 1) in experiments
on a heart-lung preparation of a dog and an isolated rabbit
auricle.

(b) In Man
In epinephrine-treated human subjects, Hecht et al. (7) found
that Dibenamine did not reverse the pressor effect, except in one
of ten subjects, this being an individual with arteriosclerotic heart
disease. Dibenamine, however, caused the systolic blood pressure
to rise only slightly while the diastolic fell strikingly. The increase
in pulse pressure was thus rather marked.
Nickerson (13) states that in some experiments in man.
Dibenamine not only greatly reduced pressor response to epinephrine, but actually reversed it, as is seen regularly in animals.
The chronotropic and positive inotropic effects of epinephrine
on the heart in man are not affected by Dibenamine, exactly as is
the case in laboratory animals. Sinus tachycardia, increased ·cardiac
output, greater peripheral blood flow, and T-wave changes in the
electrocardiagram which epinephrine ordinarily produces are still
seen after Dibenamine administration. However, epinephrineinduced ectopic ventricular beats are decreased markedly.
Ominous types of ventricular rhythms occurring in surgical
patients under cyclopropane anesthesia can be reduced in number, shortened in duration, or even abolished by the use of Dibenamine as shown by the experience of the Department of Anesthesia of the University of Utah ( 13) . As was noted in animals
by Nickerson, larger doses of Dibenamine are needed than those
which block or reverse the excitatory responses to stimulation of
the adrenergic system .
3. Sympatholytic A ction

(b) In A nimals
The response to both direct and reflex sympathetic nerve
stimulation after Dibenamine administration has been studied in
animals .in a variety of expetiments. Nickerson ( 13, 14) demonstrated the reversal by this drug of the vasopressor response to
electrical stimulation of splanchnic nerves. This is seen both in
the intact animal and after bilateral adrenalectomy. This latter
operation ensures the demonstration of the effect of D ibenamine
on the splanchic nerves alone since it makes impossible the release
of adrenalin or any sympathin into the systemic circulation. Somewhat larger doses of the drug than those which blockade epine-
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phrine and circulating sympathin are required to be effective
against adrenergic nerve stimulation.
In addition to blocking of this regional sympathetic nerve discharge, Dibenamine has been shown {13, 14) to reverse the
pressor response to generalized sympatho-adrenal discharge.
Atropinized cats were injected with a large dose of carbaminoylcholine. Atropine prevents the vasodilator and cardiodecelerator
effect of this choline ester leaving intact one element only of its
nicotinic properties: the ability to stimulate the sympathetic
ganglia and the adrenal medulla. Dibenamine is able to reverse
both components of the rise in blood pressure; and, after bilateral
adrenalectomy, to reverse the single rise due to sympathetic
ganglionic discharge alone.
Reflexly-elicited generalized adrenergic discharge is also
blocked by Dibenamine. Nickerson {13, 14) reported experiments
on cats subjected to periods of anoxia after Dibenamine. The
expected rise in blood pressure is converted by this chemical to
a fall.
(b) In Man
The response to reflexly-elicited sympathetic nerve stimulation in human subjects after Dibenamine administration was
reported by Hecht {7) . Studies were made with the cold pressor,
breath-holding and Flack tests. In each of these Dibenamine
either markedly diminished, abolished, or reversed the expected
vasopressor response. The orthostatic hypotension developing
after Dibenamne, referred to above, also illustrates the blocking
of reflexly-elicited sympathetic nerve stimulation so that postural
vasoconstriction does not occur.
4. Action on Sympathomimetic Amines Other Than Epinephrine
(a) In Animals
The effect of previous Dibenamine administration on the
responses to some 25 sympathomimetic amines has been tested.
With all of these the customary pressor response is markely decreased although it is reversed in only certain cases {13). Complete blocking and reversal is seen with amines having ~e
3-4-catechol nucleus and an aliphatic substitution on either the
nitrogen or the beta carbon. Reversal is more difficult with
amines which have a single hydroxyl group on the aromatic
nucleus. Special conditions are required to reverse straight chain
amines, those with an unsubstantial aromatic ring, and those with
an aliphatic substitution on either the nitrogen or the beta carbon.
To give specific instances, it has been found that Dibenamine
in its usual dosage does not completely block the effects of tuamine or of benzedrine. This will mean, in a practical way, that
these drugs could be used to elevate Dibenamine-depressed blood
pressures in cases where this should prove necessary.
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Nor-epinephrine, according to several investigators as, for
instance, Goldenberg et al ( 4) , is actually Sympathin E, one of
the two sympathins whose existence was first proposed by
Cannon and Rosenbleuth in 1933.
If this is true, Dibenamine, which has been shown to block
the excitatory effects of epinephrine but not its inhibitory effects,
might be expected to block but not reverse the vasopressor effect
of nor-epinephrine. This has been shown to be the case (13).
(b) In Man
One of Hecht's experiments (7) tested the effects of Dibenamine on neosynephrin when both drugs were given intravenously
to 22 patients. This sympathomimetic compound is one of the
type which appears to possess a predominant peripheral action in
most individuals and to have few of the excitatory effects on the
heart of epinephrine. It is noted that the bradycardia caused by
reflex vagal slowing secondary to the usual rise in blood pressure
does not occur when Dibenamine has been administered previously . This is apparently due to the prevention of a vasopressor
response to the amine. As with epineohrine, Dibenamine prevents abnormal cardiac rhythms. here those of the type which
result from "sinus default" or "vagus escape".
The fact that Dibenamine's main action on sympathomimetic
amines is a blocking of their excitatory powers, especially with
regard to the cardiovascular svstem, lends weight to the conception of Gaddum and Kwiatkowski. 1938, that these drugs exert
their sympathomimetic effect on the body by preventing the
destruction by oxidation of epinephrin and sympathin.
5. Action on Certain Non-adrenergic Substances Which Affect
the Cardiovascular System
Dibenamine has been found to have a very slight effect against
histamine, the physiological ooposite of epinephrine. However, many
of its congeners (9) synthesized recently aopear to possess much
Jlreater potency in this resoect than the antihistamines now in current
clinical use (13). Since these substances also possess adrenergic blocking powers, an interesting field of soeculation is opened up regarding
the mechanism of action of this whole series which can allow this dual
property of opposition to certain effects of both histamine and epinephrine.
The effect of Dibenamine on the pressor response to angiotonin
has been found to be negligible (13). Specificity of action as an
adrenergic blocki~g agent appears to be one of the main characteristics of Dibenamine.
6. Action on Hypertension
The experiments with Dibenamine referred to above were made
mainly on normotensive animals and human subjects. Of great interest
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are several other investigations on experimentally-produced hypertension in dogs and on patients with various types of hypertension.

(a) In Animals
Nickerson (14) produced renal hypertension in rats by compressing the kidneys according to the technique of GroHman.
Dibenarnine was administered orally and resulted in a marked
decline in the hypertenisve level of the blood pressure. This persisted for several days after the last dose of the drug. Nickerson
believed at the time that this experiment might afford a ray of
hope for the use of Dibenamine in lowering chronic renal hypertension in man. However, in a later article (13) , he admits that
evidence for the value of Dibenamine (as for the value of other
adrenergic blocking drugs) for this purpose is still inconclusive.
(b) In Man
Hecht (7) found that in cases of hypertension in human subjects, Dibenarnine occasionally lowered the blood pressure
toward normal levels, but that this reduction was never striking.
He attributes this failure of Dibenamine to the relatively small
doses which can be safely administered in man, 6-7 mgm.jkgm,
as opposed to approximately 20 mgm .jkgm. in animals. ·
Console (2) who investigated the effects of both tetraethylammonium and Dibenamine on 96 patients with peripheral vascular disease and hypertension found that neither of these drugs
consistently reduced the blood pressure for a period long enough
to be of value in the treatment of hypertens~on , nor even to aid
in the selection of patients for sympathectomy.
Haimovici and Medinets ( 6) report results at variance with
those of Hecht and Console. They found that Dibenamine was
always able to lower blood pressure toward normal in patients
with early or only moderately advanced essential hypertension.
A single intravenous dose of Dibenamine caused a really significant lowering of the blood pressure, and one whose duration was
many hours. This reduction could be maintained if the drug was
administered at properly timed intervals. In patients with malignant hypertension no change resulted from the use of the drug.
Spear and Griswold (21) reported a case of intermittent
hypertension, due to the presence of a pheochromocytoma, where
the hypertension was definitely reduced to normal limits with ·
every injection of Dibenarnine. The drug here aided in proving
the diagnosis of the tumor in a way less dangerous than the older
method of using histamine to provoke an attack (20) and more
definitely than by the more recent method of nullifying an attack
for a very brief period by the use of a benzodioxane compound
( 5). Dibenamine, because of its prolonged effect in lowering the
blood pressure, which remained within normal limits for 24
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hours, and in allaying the symptoms, which did not recur for 72
hours, was very helpful in building up the health of the patient
prior to surgery.
It would appear, therefore,. that Dibenamine lowers hypertension in man : ( 1) by attacking the excessive sympathetic tone
which, many investigators believe, plays the primary role in the
genesis of at least essential hypertension; (2) by rendering
ineffective any circulating sympathin or epinephrine, as shown
most clearly when a pheochromocytoma is present. Thus both
the sympatholytic and adrenolytic properties of Dibenamine ar-e
concerned in its action on hypertension. How useful this action
is clinically is still a matter not finally elucidated.
7. A ction on Peripheral Blood Flow
Hecht (7) found that visible peripheral vascular dilation was not
observed in resting normal individuals after Dibenamine administration, but was seen in subjects with peripheral vascular disease, e.g.,
hypertension, thromboangitis, Raynaud's syndrome, etc. A marked
rise in skin temperature was noted in these cases. Apparently Dibenamine is able to block the excessive sympathetic tone governing peripheral vessels in these conditions and thus permit more vasodilation.
Console's findings (2) were similar to those of Hecht. His investigations proved that peripheral blood flow in subjects with acute vascular occlusions could be effectively increased by the use Dibenamine,
and that this action was much more prolonged than that of tetraethylammonium. In chronic vascul ar occlusions, temporary vasomotor paralysis can also be caused by D ibenamine, but its value here is more
doubtful. However, Dibenamine may be useful in selecting certain of
these patients for sympathectomy.
8. A ction Opposing Lethal Adrenergic A ctivity
(a) Administration of Fatal Doses of Epinephrine
Raab and Humphreys (17) fou nd that Dibenamine protects
the heart of rats from normally fatal doses of epinephrine and
permits their survival with normally fatal accumulations of epinephrine in the myocardium. Dibenamine is far more effective than
Prisco! , or 933 F in this respect.
Loew and Micetich (9) reported that Dibenamine protects
mice against toxicity of epinephrine injected two hours later.
However, they feel that the magnitude of the dose required and
the slowness of onset of the protective action of the drug do not
justify the designation of D ibenamine as the powerful adrenergic
blocking agent Raab and H umphreys considered it to be. This is
especially evident when Dibenamine is contrasted with other
mo re active members of its own family , the beta chloroethylamines. However, Dibenamine is admittedly superior to Priscol,
Yohimbine and the Fourneau compounds.
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(b) Excessive Sympathetic Activity Following Shock
Ordinarily excessive compensatory vasoconstruction follows
severe haemorrhage and this leads to the shock state. Wiggers
et aL (22) found , in experimenting with dogs, that the administration of a very small dose of Dibenamine (2-4 mgm.jkgm.) in
the middle of the post-haemorrhagic hypotension period improved the blood flow to such organs as the kidneys, liver, and
intestines even under the prevailing low blood pressure. .Apparently the abolition of severe vasoconstriction delays the onset of
irreversible shock, for SO% of the Dibenamine-treated group
survived as compared with 30% of the controls.
Remington et al. (18} conducted somewhat similar experiments with dogs. However Dibenamine was administered one
hour before, rather than after, the haemorrhage was begun. In
the treated dogs the survival rate was 90% after a haemorrhage
of 30 c.c. among the controls only 7% survived. Pulse rate and
blood flow per second were consistently greater in the treated
group.
These investigators also tested the effect of Dibenamine on
the shock following muscular trauma. Of the group of dogs
treated with Dibenamine before the administration of multiple
blows with a mallet on each hind-leg, 89% survived; of the controls 100% suffered fatal shock. Dibenamine's protective activity
seems to be due to its prevention of the high degree of vasoconstriction which follows muscular trauma, apparently brought
about by afferent nervous discharge from the traumatized limbs.
The largest part of this description of the pharmacodynamics of
Dibenamine has been confined to the action of this chemical on the
cardionvascular system . This has been deliberate since the action of autonomic drugs can usually best be studied with reference to this system.
Workers qave been able to perform clear-cut experiments and to record
the changes in a system which is sensitive to small amounts of sympathin
or epinephrine and also of their opponent, Dibenamine.
However, there are a number of other interesting actions of Dibenamine on the body which should also be mentioned .
ll. A ctions on the Eye
(a) In Animals
In intact animals Dibenamine causes miosis, ptosis of the eyelid , and marked extension of the nictitating membrane.
Dibenarnine prevents or reduces the mydriasis, widening of
the palpebral fissure, and retraction of the nictitating membrane
usually induced by administration of epinephrine or by cervical
sympathetic nerve stimulation (14).
(b) In Man
Miosis appears early and persists for the duration of Jtction of
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Dibenamine, and is the most sensitive indicator of the activity of
the drug (7).
The effect of Dibenamine on the ciliary body and accommodation is not yet known; when the effect is discovered it may
provide information as to the role of the sympathetic nerves in
accommodation.
Ill. Other Actions of Dibenamine
(a) In Animals
1. Dibenamine abolishes the pilomotor response to sympathetic
nerve stimulation ( 14).
2. It prevents the contraction of the spleen which is largely responsible for the erythremia and leukocytosis which normally
occur during excitement (14).
3. It blocks the response of denervated effector cells to epinephrine so that when Dimenamine is previously administered
they fail to respond to 100 or more times the effective
dose (13).
(b) In Man
1. The nasal mucosa becomes congested after Dibenamine in
many of the human subjects tested (7).
2. Spontaneous sweating in certain body areas is prevented by
Dibenamine (7, 13). This is an interesting finding because,
although the sweat glands are innervated by fibres from the
sympathetic system, they are generally considered to function
under the direction of the parasympathetic. However, some
sympathomimetic amines cause sweating; epinephrine does .
not do so presumably because of its local vasoconstricting
action. Nickerson (13) reports a study by Haimovici of
palmar sweating and its inhibition to a marked deg ree by
Dibenamine. Moreover, the sweating caused by neosynephrine is completely blocked by Dibenamine. Jt seems
likely, therefore, that adrenergic sweating in certain cutaneous
areas of man is a normal body process; Dibenamine may help
to elucidate the complex mechanisms of sweating.
IV. Certain Responses Not Affected by Dibenamine
1. The respiratory effects of epinephrine are not altered, i.e. the
transient "epinephrine apnea" is not blocked by doses of Dibena;
mine which readily reverse the blood pressure response; hyperventilation, elicited by large doses of epinephrine, still occurs; the
bronchial musculature is believed to relax as usual ( 13) .
2. The metabolic effects of epinephrine are not altered by Dibenamine. For instance, the rise in blood sugar is not prevented; in
fact it occurs more quickly after Dibenamine for the epinephrine
more readily enters the systemic circulation since it no longer
limits its own absorption by local vasoconstriction ( 13) .
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3. Smooth muscles which are relaxed by epinephrine or sympathetic
stimulation are uninfluenced by previous administration of
Dibenamine, e.g. the intestine and the non-pregnant cat uterus
still relax after this drug when stimulated adrenergically. However, in contrast the rabbit uterus which is normally stimulated
by epinephrine to contract, relaxes when Dibenamine is previously administered. This is further evidence that Dibenamine,
which cannot block the inhibitory adrenergic functions, is fully
able to block any excitatory ones (14).
4. The functions of the gastrointestinal, genitourinary and somatic
neuromuscular systems are nol apparently changed. Similarly
body temperature and the blood picture are not altered. Not much
is yet known of the action of Dibenamine on renal haemodynamics
and renal function ( 13) .
TOXICITY
I. Side-Effects
1. Oral Administration
Rockwell (19) found that the only reactions to enteric-coated
capsules were nausea and vomiting in 5 of 50 patients with the
first dose. However, Hecht (7) and other investigators found that
nausea, vomiting, and burning in the epigastric area were frequent .
Moreover, pharmacological effects in doses which could be tolerated were fou nd to be unpredictable ; accordingly oral administration has been abandoned by most workers in favor of the intravenous route.
2. Pat·enteral Administt·ation
This rou te produces some unpleasant reactions, such as pain
along the injected arm, in a ma jority of patients, according to
Hecht (7) . The only safe parenteral method is intravenous infusion in hospitalized patients. Extravasation may result in pain
and local tissue damage. Direct intravenous injection sometimes
causes venous thrombosis. T oo rapid infusion may result in
nausea, vomiting, central excitation, tremors, etc. at least 60 min;utes should be taken for administration of the infusion.
II. Acute and Chronic Toxicity
1. Local Tissue Damage
As pointed out above, Dibenamine is chemically related to the
nitrogen mustards, and this in all probability accounts for the
tissue necrosis which it can inflict unless very carefully administered.
2. Central Nervous System Excitation
In both animals and man too rapid injection causes acute symptoms such as coordinated convulsiOns. The central effect is apparently independent of the adrenergic blocking action for it appears
earlier and disappears earlier than the latter action. Moreover, the
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congener of Dibenamine, N ,N -bibenzyl animoethanol, possesse~
no adrenergic blocking power, but shows a similar convulsive
action. An odd psychic feature of the central effect of Dibenamine
was a disturbance of time sensations with some hallucinatory
features and with repetitive perceptions of actual events so that an
incident just occurring seemed to have been already experienced.
This psychosis was noted in 15 of Hecht's 70 patients (7) and
lasted for two to three hours. Consciousness usually was at its
height. Psychiatrists may find Dibenamine useful for elucidating
this phenomenon which occurs without known cause in certain of
the mentally ill.
3. Only Slight Cumulative T oxicity H as Been N_oted
Nickerson reports (1 4) that growing rats subjected to daily
subcutaneous injections of 3 times the adrenergic blocking dose
for a period of 4 months showed no permanent ill effects and only
a slight decline in the growth rate during the period of treatment.
Hecht reports (7) that human subjects treated with the average
tolerated dose, 4-6 mg..fkg., showed no striking alterations in
blood counts, urinalyses, electrocardiograms, temperature, or body
functions. Of great importance is the fact that Dibenamine does
not possess the property so characteristic of the nitrogen mustards
of producing a toxic effect on the bone marrow (13) .
Ill. Therapeutic Ratio
The relationship between the effective and the toxic doses of
Dibenamine is on the order of 10 - 100. a therapeutic ratio which,
although not high, compares favorably with that of other adrenergic blocking agents. Slow intravenous administration appears to
give the g reatest margin of safety in animals (14) .
Dosa~r.e

The manufacturers of the drug state that a "single dose for adults is
5 to 7 mgm . per kg. body weight, with the average dose 6 mgm. per kg.
Regardless of weight, the single total dose should not exceed 500 mgm .
(contents of one 10 c.c. ampule) . The single dose may be repeated two
or three times weekly." (Quoted from the circular which accompanies
supplies of the ampules.)
Dibenamine is also available in enteric-coated tablets of 130 mgm.
for oral administration.
Absorption, Onset and Duration of A ction
No specific information on absorption by the oral or the various
parenteral routes is apparently available in the literature at present, probably because the intravenous route has largely displaced other methods of
administration by reason of its greater safety.
The onset of action is rather slow, especially in comparison with that
of some of its congeners (9). Loew reports that it failed to decrease the
toxicity of epinephrine until the third hour but protected the mice until
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18 hours after treatment. Nickerson "(14) states that the maximal blocking action is not observed until at least 30 minutes after administration of
the drug but that the duration of effect from a single injection is from 36
hours to 5 days. Haimovici ( 6) found that the depressor effect started at
the end of the (slow) infusion and lasted 24- 72 hours.
Although Dibenamine may be considered slow in onset as compared
to other recently synthesized beta-chloroethylamines (known in the literature as SY compounds and still very much in the investigational stage as
far as presen~ use is concerned), it i!i fairly rapid in its commencement of
action compared to other clinically available adrenergic blocking agents.
Its long duration of action is admitted by all investigators.
Mechanism of Action .
It is considered likely ( 6, 15) that the site of action is the neuroeffector cells where Dimenamine blocks the sympathetic impulses or the
action of sympathomimetic substances (sympathin E, epinephrine).
The prolonged blocking effect of a single dose of a drug which is
known to become inactivated within a few minutes at the pH of the body,
suggests, Nickerson feels, that there is "prolonged inhibition, or actual
destruction, of some structure or substance involved in the excitatory
responses to epinephrine and its slow reactivation, repair or replacement
so that complete recovery occurs without residua" {15). In later articles
-(14, 16) Nickerson rules out, by a process of elimination, "any major
effect of Dibenamine on (a) autonomic ganglia, (b) post-ganglionic
neurones, or (c) on the release, alteration or destruction of epinephrinf'
and sympathin", so that he feels Dibenamine's action must be exerted
directly upon the effector cells (i.e. vascular smooth muscle).
The action on the effector cells could then be exerted in three ways:
"(i) by preventing the penetration of sympathomimetic agents to their
site of action, (ii) by blocking or destroying some receptor substance or
mechanism necessary for excitation by these agents, (iii) or by attacking
the contractile mechanism itself." Nickerson's experiments (16) upon
the nictitating membrane of the cat lead him to favor (ii) and he discusses
at length the manner in which he believes Dibenarnine may act.
Comments
The above review of the literature on this interesting new drug
shows that there is still a good deal of controversy as to the practical uses
to which it may be put, e.g. there is no general agreement as to bow useful it may be in treatment of certain conditions as hypertensive disease,
peripheral vascul.ar disease, shock, ventricular arrhythmias in patients
under anesthesia, etc. However, it seems apparent that it will be useful in
the dia_gnosis and the treatment of some. at least. of these conditions, perhaos to be displaced later by other members of its own family, once their
oharmacology and therapeutic indices are also fully worked out. Dibenamine does seem to have certain advantages in soecificitv of action, long
duration and completeness of blockade, and wide margin of safety over
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some of the drugs currently in use as adrenergic blocking agents, e.g.
Yohimbine, Priscol, the Fourneau benzodioxone componds, tetraethylammomium, etc.
Interesting new vistas of speculation and experimentation are opened
up by the discovery of so active a drug, quite apart from its immediate
practicality. The whole field of autonomic activity can be reviewed with
fresh interest and Dibenamine can be used as a convenient tool in the
attempt to elucidate more of the mysteries of the sympathetic and the
parasympathetic systems.
New possibilities of investigation may also arise from the central
effects of Dibenamine, and psychiatry gain new knowledge. It is interesting to note that one experimenter, Medinets (11), has already
announced certain discoveries with regard to the catatonic state of schizophrenic patients, in this case making use, however, of the adrenergic
blocking action of the drug.
The workers on Dibenamine, scattered in laboratories and clinics
over most of the continent, have gradually built up a large store of information on this drug in the last three years. Further coordinated studies on
it and its congeners should soon prove tremendously worthwhile both for
the field of Medicine and the field of Pharmacology itself.
Summary
Dibenamine, one of a new series of potent, specific and long-lasting
adrenergic blocking agents, has been investigated by laboratory and clinical workers since 1946. Chemically related to the nitrogen mustards, it
must be carefully administered, preferably by the intravenous route, to
avoid causing tissue necrosis similar to that caused by these related substances. Its systemic effect is to cause blockage of all excitatory adrenergic functions , thereby often throwing into relief concurrent but previously invisible inhibitory adrenergic functions which it is unable to block.
A variety of experiments which have been performed on both laboratory
animals and human subjects to demonstrate its pharmacodynamics are
then described . These pertain chiefly to Dibenamine's action on the cardiovascular system for it is here that the most dramatic and potentially the
most clinically useful results of its opposition to epinephrine andj or
sympathetic nerve stimulation are apparent. It is notable that Dibenamine
does not affect the chronotopic or positive inotopic effects of epinephrine
on the heart; it opposes chiefly the peripheral vasoconstriction which
epinephrine .induces.
The acute toxic effects of Dibenamine are local tissue necrosis and
central excitation, both of which can usually be avoided by a careful and
slow intravenous administration of the drug. Chronic toxic effects are
usually not noted as there is only slight cumulative toxicity. The therapeutic ratio, although not high, compares favorably with that of other
adrenergic blocking agents.
The possible mechanism and site of action of Dibenamine, the duration of effects and the dosage used are discussed. Possible clinical and
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laboratory uses for the drug are suggested and a comparison of its effectiveness with that of other adrenergic blocking agents is made.
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PORPHYRIA
By J. E.

MULLENS, '49

is a name given to a group of conditions which are due
P OR-PHYRIA
to inborn errors in metabolism and characterized by the excretion of
porphyrins in the urine. One must be careful to distinguish the term
porphyrinuria (porphyrins in urine) from porphyria. Although porphyrins occur in the urine in porphyria, not all porphyrinuria is due to porphyria. Porphyria is a disease enttty, while porphyrinuria is merely a
symptom.
In the last few years a great deal of interest has arisen concerning the
role of porphyrins in health and disease. As yet the subject is in a state of
flux, and the center of much controversy. Therefore, this paper cannot be
too dogmatic or authoritative, its main purpose being to stimulate interest
in the porphyrins and their relation to clinical medicine.
Before the clinical aspects of porphyria can be discussed it is essential that a very brief reference be made to the chemistry of the porphyrins.
A few facts must be known in order to have some idea of etiology, and
of the detection of porphyrins in the urine--a clinical necessity.
Chemistry of Porphyrins
Every porphyrin is composed of 4 pyrrol nuclei joined by methene
bridges to form a ring. Each pyrrol nucleus is a five membered ring with
4 carbons and a nitrogen and 5 replaceable hydrogens. When these are
linked together to form the porphyrin nucleus there are 8 replaceable
hydrogen atoms present. Individual porphyrins are determined by the 8
side groups which each may possess. Hans Fischer synthesized 4 aetioporphyrins, which have 4 methyl and 4 ethyl radicals. Four differing
arrangements are possible and thus these aetioporphyrins are named I, II,
III, and IV. All other porphyrins are named according to which aetioporphyrin their configuration corresponds, regardless of the substituted
radicals.
All naturally occurring porphyrins belong to I or III. II and IV configurations or types have never been found in nature. The porphyrins of
the respiratory pigments, i.e. hemoglobins, cytochrome, catalase, as well as
the free protoporphyrin of the erythrocytes all belong to type III. Coproporphyrin I occurs naturally in meconium, feces, and urine. T ype III,
coproporphyrin, also occurs naturally in the urine. The prefix copro is
used because it was first isolated from the feces.
It is important to note here that it is quite unlikely that a type I
porphyrin could be derived from a type III porphyrin (or vice verse) in
nature because this could only happen by the breakdown and resynthesis
of the whole molecule. Thus the coproporphyrin I in urine cannot be derived from the respiratory pigments. This formation of 2 types of porphyrins in nature independent of each other is what Fischer called the
"dualism of the porphyrins" .
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Uroporphyrin is a porphyrin first isolated from the urine and later
from the feces. It occurs only in pathological states and is evidence of a
constitutional biochemical fault.
·
Physics of Porphyrins
The name porphyrin comes from the Greek word porphuros, meaning crimson or purple. Porphyrins ar~ reddish-brown to red, depending
upon their solvent, and its pH.
The absorption spectra are characteristic but a · very precise spectrometer is required . The old spectrometers were the cause of the artificial
haemato-porphyrin being confused with natural · porphyrins, as their
absorption spectra are quite similar.
In the longer waves of ultra violet light there is intense red fluorescence. The emission spectra in ultra violet light is characteristic but does
not separate the isomers. The identification of isomers depends upon
(1) melting point of the crystalline methyl esters, (2) crystalline form,
(3) fluorescence curves obtained from porphyrin solutions of varying pH.
PORPHYRIA
Clinically there are 3 types of porphyria. Gunther named these congenital, acute, and chronic. Recently the term "chronic" has fallen into
disuse. Waldenstrom prefers the term "porphyria cutanea tarda" be substituted for the term chronic. He identifies it as a late form of congenital.
Many do not mention chronic in their classification.
It should be noted here that the term haemato-porphyria is archaic
and incorrect despite its persistence in some good texts.
I. Congenital Porphyria
·
This is inherited as a Mendelian recessive. It occurs usually in males
and usually before the age of 15 years. It is much less common than acute
porphyria. It runs a long and debilitating course, death finally being due
to intercurrent disease or anemia.
Red urine is the first sign of the disease and may precede the skin
lesions by weeks or years. Tests show the porphyrins are uroporphyrin I
and coproporphyrin I. Isolated instances of type III porphyrins in the
urine have been reported.
There is characteristically a hypersensitivity to light. This manifests
itself in skin lesions of a bullous nature. The bullae are large, show no
umbilication, and are distributed chiefly on the exposed portions of the
body. It begins with itching or burning of the skin, photophobia and
conjunctivitis. There may be oedema and hyperemia of the face. At the
same time malaise, nausea and headache are common. When uncomplicated the lesions heal with little but definite scarring. Suppurative lesions
occur in the presence of secondary infection, and when this is present,
marked scarring, deformity, and disfigurement of the hands and face
occurs. The scars become pigmented. This skin affection occurs typically
in the spring and summer unless the patient is protected from sunlight
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and is therefore called hydroa aestivale or vacciniforme. It must be noted,
however, that all hydroa aestivale is not due to porphyria.
Ocular damage may occur from scarring and deformity. Such lesions
as conjunctivitis, chemosis, bullae on the cornea, leukoma, posterior
synechia, and symblepharon occur. The lids may be narrowed, or ectropion may result.
The fingers and nails are often deformed. The nails may be lost, and
in some cases may be red in colour.
Erythrodontia, or red teeth, are an interesting feature of the disease.
The colour, though, may range from distinct red or brown to normal.
Endocrine disorders seem common, e.g. toxic goitre, hirsutism, etc.
Borst and Konigsdorfer found morphological changes in the endocrine
glands.
Hepatomegaly andj or splenomegaly occur, more commonly splenomegaly. The splenomegaly may not be found in the young but usually
appears as the patient grows older.
Anemia is a significant feature of the disease. Normoblasts, megaloblasts, punctate basophilia, and polychromasia have been seen. Megaloblasts are rare in the blood, and though they occur in the bone marrow,
the colour index usually diminishes as in any secondary anemia.
The feces are not characteristic unless the porphyrin content is high,
then they become black on oxidation. Both coproporphyrin and uroporphyrin are present.
Congenital porphyria has no heredity connection with acute porphyria, although Nesbitt and Katkins have seen a family where one member had acute porphyria and another had congenital porphyria.
Differential. Diagnosis of Congenital Porphyria
The skin lesions are not pathognomic. The deforming character may
resemble lupus or leprosy. Scleroderma may be simulated. The lesions
may be confused with epidermolysis bullosa because trauma also raises
vesicles in some cases of porphyria. A urine examination should be sufficient in most cases to differentiate, however, if the urine is negative for
porphyrins it does not rule out congenital porphyria and the blood serum
should be examined.
The skin lesions and the teeth may show fluorescence in near-ultraviolet rays if the porphyrin content is high enough.
Splenomegaly may be present but the spleen is not as large as in the
splenic anemias. This could confuse due to the anemia which is often
present in porphyria. Because the splenomegaly only appears with time
it is presumed to be secondary.
The anemia present is often associated with signs of abnormal bone
marrow activity, e.g. normoblasts, erythroblasts, megaloblasts, and erythrophagocytosis. Petry, the original classical case of congenital porphyria,
showed the picture of pernicious anemia late in the course of the disease,
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and an indirect Van den Bergh reaction. Here again the examination of
the urine will usually differentiate.
II. Acute Porphyria
This disease is inherited as a Mendelian dominant with a low incidence of expression. Contrary to the name it is actually a chronic disorder. It is more common in women and in the third to fifth decades.
There is usually a high mortality after a relatively short duration, due to
respiratory paralysis.
Some people distinguish a toxic and an idiopathic form. Gunther
originally, and many authorities since, think that toxic substances only
precipitate the symptoms of a condition already present. Toxic porphyria
may be precipitated by lead poisoning, barbiturates, sulfonal, trional and
other substances. There is no justification in recognizing a toxic form as
the symtoms are identical and only the history can differentiate.
SYMPTOMATOLOGY
1. Abdominal symptoms: Severe abdominal pain of a colicy type is commonly one of the first symptoms. It is often in the lower abdomen but
may become generalized. Radiation to the thighs is not uncommon.
A case has recently been reported in which there was urgency of micturation during the acute attacks. The abdomen is typically soft. The
attacks may be often seen post-partum, or associated with the menses.
Nausea and vomiting are usually present and frequently severe.
Constipation is nearly always present and may be quite severe. Diarrhoea occurs but rarely.
2. Jaundice occurs sometimes and is usually mild . This is to be distinguished from the comm nl y occurring diffuse skin pigmentation. This
pigmentation occurs chiefly on the face and abdomen and may be in
freckle or chloasma-like spots, especially on the face. This pigmentation does not involve the mucosal surfaces. There is often darkening
of the hair. The acute attack may be preceded by years by the pigmentation, which may become worse during attacks. Incidentally the cause
of the pigmentation is unknown.
3. Hypertension and tachycardia occur often and especially during
attacks.
4. Oliguria is commonly present.
5. Neurological and Mental Symptoms: Porphyria may play a
minor role in the production of the neurological symptoms as porphyrinuria may occur after the symptoms have been established. Contrary to the prevalent idea, Wildenstrom states that an ascending
paralysis is not the commonest neurological symptom, although this
Landry form of paralysis is common.
There are often irregularly distributed paresis. There may be
only a single group, or nearly all striated muscle may be affected.
Symptoms similar to those of polyneuritis may be marked. Convulsions, delirium and coma are sometimes seen.
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Hysteria is a common diagnosis because of the curious paresis and
pains all over the body. There may be initially a feebleness which can
be overcome by strong volition. This is a hysterical picture. The passing attack of blindness which can occur may be diagnosed hysterical
amaurosis. Paralysis is usually preceded by nervousness, irritability,
pain in the lower extremity, or discomfort and aching. Such sensory
disturbances as hypaesthesia, or paraesthesia may be present. These
symptoms may precede the abdominal pain by a few days to a few
weeks.
Paresis and loss of reflexes in the legs and soon involving the
arms is often seen. Complete flaccid paralysis may ensue. During this
2 - 3 week interval the patient may be irrational. Visual and auditory
hallucinations are encountered, and delirium may alternate with
apathy. there may be other psychopathic phenomena, e.g. maniacal
or depressive states, or epileptiform seizures. A true Korsakoff's
psychosis may develop, viz.: acute toxic psychosis with polyneuritis.
Waldenstrom points out that many porphyries are in asylums. In
studying the family history of porphyries it seemed to him that there
were more than an average number of manic-depressives and schizophrenics in the family. Watson suggests that it would be a good idea
for someone to survey the clinical material in our mental hospitals as
Waldenstrom did in Sweden, and doubtless many porphyries would
be discovered.
In the late stages of the disease bulbar paralysis and therefore
dysphagia and dysarthria are commonly seen. Amaurosis and ocular
palsies are also seen. Finally incontinence, coma and death ensue.
Mild cases have recovered and some others have had remissions
and relapses.
6. The urine is usually a burgundy red or amber, becoming red on exposure to light. The appearance of the red colour is hastened by oxidizing
agents. Originally it was said that the urine contained uroporphyrin
III and I and in some cases coproporphyrin II:t. However, recent work
has shown that what was formerly considered uroporphyrin III is
actually uroporphyrin I with an unidentified type III porphyrin.
The chromogen porphobilinogen is present in the urine and is
specific for acute porphyria. It is stable when in alkaline urine but
when acid it becomes porphobilin and what was formerly known as
uroporphyrin III. Porphobilin was formerly known as urofuscin, and
is simply a pigment. Some porphyrins in both acute and chronic porphyria are commonly excreted as complex metallic compounds-zinc
especially.
7. Photo sensitivity has been reported but is extremely rare.
8 . The following also have been noted :
(a) Sudden development of Grave's disease
(b) Ob'esity of the Frohlich's type
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(c) Changes in the pituitary and adrenals
(d) Virgin secreting colostrum
_
(e) A man with swelling of the breasts during an attack
(f) A lesion of coeliac ganglion.
9. Remissions and exacerbations occur especially in the abdominal type.
The neurological type has a mortality of 50-75 per cent. Mixtures of
symptoms do occur commonly in any combination.
Differential Diagnosis of Acute Porphyria
1. Examination of Urine:
The urine may be red only on 'exposure to light, especially sun. Porphobilin may be responsible for most of the colour. It has been con- ·
fused with urobilin. Watson and Schwartz have devised a simple test
for the detection of urinary porphobilinogen. Equal parts of Ehrlich's
solution, urine, and a saturated solution of sodium acetate are mixed.
A few c.c.'s of chloroform are added. Porphobilinogen remains in
aqueous solution and urobilinogen is extracted by the chloroform.
More chemical procedures for the detection of porphyrin isomers
will be omitted here for brevity.
2. Abdominal Condition:
Laparotomies have been done for obstruction, appendicitis and gall
bladder disease.
There is in this condition (porphyria) a leucocytosis of 15-20,000
and a temperature of 100-102".
Gunther's triad of vomiting, colic, and constipation is almost invariably present.
The x-ray shows bowel spasm especially in the ileum. The stomach and colon may be dilated.
When an ascending peripheral neuritis is present the diagnosis is
complete, but this is not always present.
3. Neurological:
Some of the entities ~ith which it has been confused are poliomyeliitis,
progressive muscular atrophy, periarteritis nodosa, cerebral tumour,
hysteria and various psychoses. Should a suspicion of porphyria be
present, the simple test outlined above will decide the ·issue in most
cases.
111. Chronic Porphyria
No genetics are known about this condition." The symptoms of both
congenital and acute may be present in a milder form. Waldenstrom believes it is a form of congenital porphyria.
The skin is somewhat sensitive to light. Abdominal or neurological
symptoms may be present singly or in combination. Severe neurological
symptoms are not present.
Coproporphyrin I and III and. uroporphyrin I and III are excreted in
the urine. Gray, Rimington and Thomson mention only uroporphyrin III.
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Chronic porphyria develops later in life, and a sclerodermic tendency
is noticeable.
Before studying the etiology the pathology should be summarized:
Pathology
1. Congenital Porphyria:
The skin lesions show necrosis of the epidermis due to capillary damage in the corium. It is not primarily epithelial, therefore, but vascular.
The teeth vary from red to normal and contain uroporphyrin I.
Uroporphyrin I and coproporphyrin I are found in the cells of the
bone marrow. U roporphy.rin I is also deposited in the bones. There
is hemosiderosis of the bone marrow, spleen, and liver.
2. Acute Porphyria:
Hepatic damage has been noted frequently. Recently Gray, Rimington
and Thomson noted significant changes in the hippuric acid test when
jaundice was present. In addition to disturbed liver function , disturbed
calcium and cholesterol metabolism have been observed.
Abrahams, Gavey and Mclagen reported a case in 1947 in which
low serum chlorides and serum sodium were present. To their knowledge these determinations have not been done in other cases. They
noted that during exacerbations the symptoms were much like adrenal
insufficiency though at autopsy the adrenals were anatomically normal , and therapeutically adrenal cortical extract and sodium chloride
did not avert death.
Prunty observed liver damage, hemosiderosis of liver and porphyrin in the liver cells. The kidney and the costal cartilages also
contained porphyrins. Waldenstrom has found arteriolar medial
sclerosis and necrosis.
ETIOLOGY
A . General
Porphyria has a universal distribution, and is not peculiar to humans.
Typical congenital porphyria has been found in pigs and cattle. It is
interesting, however, that nearly all of Sweden's porphyries reside in one
province.
It has been said before that some porphyrins are in the urine normally. The source of coproporphyrin in urine and feces is not likely to be
meat because it may be found in vegetarians. There is a possibility that
excretion is related to hemotopoietic tissue because excretion rises when
hemotopoiesis is increased. Watson says that both uroporphyrin I and
coproporphyrin I are formed in the erythrogenic cells of the bone marrow. Coproporphyrin I excretion increases in pernicious anemia and in
hemolytic jaundice.
All of the porphyrins sensitize to light in varying degree but porphyrinogens and metallic salts of porphyrins do not. Uroporphyrin has the
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most photodynamic action of all. They also produce smooth muscle spasm
which is intractable to atropine. Intestinal colic, hypertension, oliguria,
retinal vessel spasm and peripheral neuritis are regarded by some as porphyrinopathic whether it be idiopathic or toxic porphyria, e.g. lead
poisoning. Porphyrins are excreted in large amounts in congenital porphyria, and less so in acute porphyria. This has been given as a reason
for photosensitivity in congenital porpliyria. But this would mean that
there is something wrong with the porphyrinopathic theory of bowel
dysfunction because there is none in congenital porphyria. Turner says
that the difference lies in the fact that the porphyrins are metal complexes
in acute porphyria and not in congenital porphyria. Yet Watson has
demonstrated free porphyrin in the blood serum without photosensitivity.
Porphobilin also has been under suspicion as the cause of the
pathology.
Berg believes that porphyrins may produce a block at neuromuscular
transmissions and inhibit acetylcholine at the synapses. It may interfere
with the hydrolysis of acetylcholine in its relation to choline esterase or it
may interfere with the synthesis and release of acetylcholine. It is interesting to note that uroporphyrin occurs normally in foetal bones.
B. Porphyrins in Drug Ingestion
1. Lead Poisoning:
Coproporphyrin III and a little coproporphyrin I are excreted in
the urine. Increased light sensitivity has been reported. Calcium
chloride administration clears the porphyrinuria and fluorescence
from bones. The urinary coproporphyrin is rarely large enough to
give red urine. Uroporphyrin III has not been observed. Yet the
symptoms are practically the same as those of acute idiopathic
porphyria. Even in ordinary lead poisoning the toxic manifestations have been attributed to porphyrinopathic sequelae. The
lesser degree of symptoms . corresponds to a lesser degree of
excreted porphyrins. Thus the calcium given therapeutically may
remove circulating porphyrins as insoluble calcium compounds
and deposit them in bone.
2. Sulfonal and Trional Ingestion:
Porphyrinuria here occurs almost entirely in women. Uroporphyrin
I and III are reported as having been excreted.
3. Salvarsan Injections:
An increase in urinary coproporphyrin III occurs in some patients
receiving injections, and in salvarsan dermatitis, but not always.
4. Phosphorus:
Causes an increase in urinary coproporphyrin .
5. Selenium and Mercury:
May cause increased excretion of coproporphyrin and also uroporphyrin.
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6. Alcohol:
Increase in urinary coproporphyrin III.
7. Barbiturates:
Controversial.
C.. Seconda-ry or Symptomatic Cop-roporphyrinuria
1. Jaundice and Liver Diseases:
(a) Hepatic cirrhosis:
The fatty cirrhosis following chronic alcoholism causes an
increase in coproporphyrin III excretion, while non-fatty,
idiopathic or post infective cirrhosis causes an increased excretion of coproporphyrin I. The reason for this is not clear. But
it is known that acute alcoholism temporarily increases coproporphyrin I excretion.
(b) In Infectious Hepatitis coproporphyrin I is excreted in
increased amounts.
2. Poliomyelitis:
There is excretion of urinary coproporphyrin III. Incidentally
coproporphyrin III is present in the white matter of the central
nervous system. This may or may not be significant.
3. Anemia:
Aplastic and hyporegenerative types increase the excretion of
coproporphyrin I and III.
4. Hodgkins' Disease and Leukemia also increase coproporphyrin
excretion.
5. A class of patients who appear to have functional bowel complaints
have increased coproporphyrin excretion. Watson poses the question, are the porphyrins responsible or are they indicative of a
primary autonomic nervous system disturbance?
Where do porphyrins come from? It has been hypothe:;ized that uroporphyrin III may arise from disturbed synthesis of respiratory pigments
or abnormal destruction of hemoglobin.
Dobriner and Rimington separately have hypothesized that the formation of porphyrins is under enzymatic control. If a porphyrin ring is
split transversely two dipyrromethane rings are formed. Designate these
X and Y and assume they can occur separately in the body. Then
X + Y = type III porphyrin
X + X = type I porphyrin
Y + Y - does not occur
These reactions are under enzymatic control and normally III and I
types are produced in a constant ratio. Porphyria could be a disturbance
of this enzymatic control.
In summary, one sees porphyrinuria in many clinical syndromes. In
considering the etiology of po_rphyria it is interesting to note all the foregoing data that it might shed some light on the cause. As yet, the details
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of etiology arc obscure but it does appear as though porphyria has some
tie-up with the symptomatic porphyrinurias.
SUMMARY
Treatment of Porphyria
1. A void sul phonal, trional, lead, selenium, barbiturates, sulfonamides,
arsenicals, alcohol and phosphorous.
2. Abrahams, Gavey and McLagan suggest kaolin be given to absorb
porphyrins in the bowel, but Watson maintains porphyrins in the
bowel have no relation to urinary porphyrin excretion.
3. Neostigmine and mecho lyl have been used in acute porphyria with
dubious results. Berg thinks they may actually be dangerous.
4. Liver injections have been used in chronic and acute types with controversial results. Theoretically the liver destroys porphyrins.
5. Demerol and atropine are useless in acute porphyria.
6. Alkalinizing the urine to decrease porphyrin excretion is useless.
(Jorgensen and With) .
7. Calcium chloride may or may not be of value.
8. Protect congenital porphyries from trauma and sunlight.

Discussion
It is apparent that the investigations into a rare condition, porphyria,
have opened up a vast new field for study in medicine, namely the role of
porphyrins in health and disease. For example, what is their relation to
liver disease, virus diseases such as poliomyelitis and infectious hepatitis,
heavy metal poisoning, aplastic anemias, polyneuritis and mental disease?
It has been the object of th is paper to stimulate interest in porphyria so it
may be recognized , and in the relation of porphyrin metabolism to other
aspects of clinical medicine.
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~bstracts
NEW POSSIBIUTIES IN PRIVATE
PSYCIDATRIC PRACTICE

c.
Am. f .

P.

Psy~hiaJ.

The author believes that socialized or state
medici ne may eliminate the private psychiatrist. But if present trends remain the same
in this country (U.S.A.), private psychiatric
practice will prosper providing it offers better ervice at Jess expense.

0BERNDORF

105:589-593, Feb. '49

After a brief account of the history of
psychiatry and an evaluation of psychiatric
methods, this article proceeds to consider
certa.in problems and deficiencies in the practice of psychiatry. The psychiatrist, himself,
is considered first. The isolating nature of
the work of a private psychiatrist tends to
limit his range and vision. To overcome this,
the author suggests a part-time position in a
sanitarium or other institution.

-EWAllT SCHENCK, ·~0

GRAVES' DISEASE: TREATMENT
WITH RADIOIODINE (I m )
MAYO

H.

SOLEY, EAlu.

R.

MILLER AND

NADINE FOREMAN

f . Clin.

Endo~rinol.

9 :29-35, f an. '49

One of the most promising of the medical
implications in the study of radioactivity is
Next, the matter of cost of treatment is
the application of radioactive iodine in treatconsidered. At prese.nt, 90 % of the popul aing Graves' disease. In effect, the intention
tion cannot afford private psychiatric treatis to perform a sub-total medical thyroidecment. A plan whereby private psychiatrists
tomy. The authors report on the use of
join in a "group practice" is advocated and
radioiodine (I 131) in Graves' disease.
the advantages of such a plan are enumerAnimal studies on rabbits and dogs showed
ated. Under such a system patients in low
an early decrease in the size of the thyroidincome groups would be treated at reduced
the ar teries showed medial and intimal
fees and this would be possible '' through the
fibrosis, thickening and perivascular fibrosis.
circumstance that a younger man, whose
Of the acini, only a few remained, these at
practice in the early years is always uncerthe poles. The amount of Joss depended upon
tain, would be assured of a definite income
the uptake of }1 31 by the thyroid. ln some
for a given number of hours' work a week."
instances, renal and tracheal damage occurred,
" Half-way houses" for the intensive treatwith no changes in other organs.
ment of mild psychiatric cases are proposed
as another facility in the private care of the
To date, 68 true cases of Graves' disease
mentally ill.
have been studied, the majority of these with
some thyroid enlargement. Dosages started
The old family doctor who knew the emowith 2~0 microcuries of radioactivity, later
tional setting of his patient is becoming exwere increased to 1000 and 4000 units, with
tinct. A new and widening function of the
a total dose up to 10,411 units.
psychiatrist is that of general family medical
counsellor. This role is often attained only
The uptake of 1131 was measured, using
after the psychiatrist has treated some memestimated weights of thyroid as judged by
ber of the family. The family psychiatrist is
palpation and compared with actual weight
consulted to evaluate proposals of other
of thyroid tissue removed in subtotal thyroidmedical specialists for treatment-especially . ectomies. It was estimated that with no prein cases where emotional factors are involvvious treatment, an average of 61% of 1131
ed. Advice is also frequently sought by the
was taken up, whereas with those patients
family in regards to choice of vocation and
treated with Lugol's iodine or one of the
other personal matters.
thiouracils, an average of 48% was taken up.
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The importance of the estimation was em·
phasized, though it was admitted that the
margin of error was high, and that the con·
centration of Jl31 per gram of thyroid tissue
was not directly related to the response.
Response is defined as satisfactory if in 4
months the signs and symptoms of thyrotoxicosis have disappeared, the thyroid has returned to normal size, and the ba al metabolic rate, level of serum protein-bound
iodine, and other laboratory fin.d ings are
normal. Of the total, 42 patients were con·
sidered to have had good response, 4 showed
a delayed response (these were more evere
cases), 2 were given subtotal thyroidectomies
(one for possible neoplasm, the other because of poor cooperation) , 3 were considered ''slow responses," ~ were unavailable
for evaluation, one became pregnant and the
remainder have not yet been evaluated .
The only complication mentioned was the
development of myxoedema in 2 female
patients. This occurred after a few weeks of
therapy, with symptoms similar to those seen
i.n the relapse of myxoedematous patients
upon stopping thyroid therapy. It is stated
that there may be some recovery in these
patients, though follow-up i not yet com·
plete.
The authors mmment that time will per·
mit resolution of the problems of election
of patients, dosage, and administration of
dosage. They conclude that radioactive iodine
(JIH) in adequate dosage will cau e a subtotal destruction of hyperfunctioning thyroid
glands in patients with Grave · di ~e~se, producing thereby satisfactory rem•s 1ons of
signs and symptoms of the di ease. " Further
studies ultimately will disclose its place in
the therapy of Graves· disease:·
-D. B. MELTZ ~R, · ~o

·EVALUATION OF THE VARIOUS
CUNICAL SIGNS OF THROMBOPHLEBITIS AND EXPERIENCES
IN THERAPY WITH ANTICOAGULANTS
DAVJ1T A. FELDER, .M.D.
SMr,.,

G,.•c. & Obsl. 88:337-3j0, 1949

Dr. Felder presents a very comprehensive
paper on the subject, in which he presents
92 cases, representing 10::1 extremities with
deep thrombophlebitis of the lower extremities.
Diagnostic signs and symptoms used were
swelling, vessel tenderness, pain, increased

temperature of limb, dilated superficial veins,
cyanosis, pulmonary embolism and change m
temperature and pulse.
The treatment used was :
1. Heparin and dicoumarol in 84 cases
(a) Heparin used for 1-2 days for
most patients. ~0 mg. intravenously
every 3 hours with clotting times ( 1Yz
hours after each dose) kept at 2 to 3
times the patient"s normal dotting time.
In some, the night therapy was given
in one dose of 100 mg. at midnight.
'Heparin in Pitkin's menstruum was
used in 7 cases (300 mg. in 1 dose/day
with a vasoconstrictor given subcutaneously) . Reports on coronamid prolonging heparin 's action are encouraging.
(b) Dicoumarol was given: 300 mg.
the first day, 200 mg. the second day
in 2 doses, and 100 mg. the third day
in 2 doses. Prothrombin time was kept
1.~ higher than the control normal for
the patient. In bleeding complications,
72 mg. Vit. K was given intravenously.
The average treatment was for 14
day, but was extended to 21 days in
cases of pulmonary embolism.
2. Bed rest-average 10 . ~ days.
3. Com~on femoral ligation was performed in 8 patients.
In this series the incidence of secondary
pulmonary embolism was 2 .17% and none
of these was fatal. The complications of
anticoagulant therapy are presented and discussed and do not appea.r to contra-indicate
its use in most cases.
The th erapy ou dined appears to be adequ ate for rno t ca es, but as Dr. Felder
tates 'The answer to the question of
thrombophlebitis does not lie in perfecting
the anticoagulants and their administration,
but rather in the fundamental cause of
abnormal blood clotting."
-EuNICE E. 0ESTilEJCHJ!R, M£os '49

MANAGEMENT OF CHRONIC
PEPTIC ULCER
La•cel, 2j6:3j3, 1949
The article deals with the management of
chronic peptic ulcer. Early treatment and
diagnosis are very essential, and many can
only hope for reasonably normal lives with
minor relapses. It is pointed out thatduring
a.c ute relapses, bed rest is definitely required
but not to the point of boredom for the

..ABsnlAcrs
patient. The change from an active life should
be gradual until the patient comes to accept
his disability.
The drastic restriction on foods is felt to
be open to question, and within reason the
patient should eat what agrees with him. A
little food , often, with proper timing and
regularity is considered of prime importance.
There is no di rect evidence that smoking is
harmfuL Schnedorf and Ivy have found that
gastric acidity is not increased ; if any effect
at all, it retards evacuation and depresses
gastri c acidity.
The barbiturates are felt to

~

the only
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drugs of value in all stages of peptic ulcer.
Belladonna in the form of !-hyoscyamine is
useful in the acute stage, because it allays
spasm and reduces painful gastric contractions, but it is of no use beyond this stage.
The danger of haematemesis from insoluble
aspirin is noted.
'"The successful management of a peptic
ulcer, then, requires on the patient's part an
avoidance of excess, a minimum of fuss, and
an acceptance of the inevitable. It asks of
the physician a humble recognition of the
limitations of therapy and a sparing .md
hu mane use of his veto."
- DoNALD M . GooD, ·::;o

THE PROBLEM DRINKER

This book can be highly recommended as
a useful and desirable book for any physician's library.

JOSEPH HIRSH

D11el, Sloan and Pearu, New York, 1949,
211

pp.,

IIIIIJI.

- KEN RITCHIE, '50

u

"Alcohol is a fact. We cannot hide it, we
cannot avoid it. We have always had it.
And as long as there is plant life on the face
of the earth we cannot prohibit its existence.
Alcoholic excesses and problem drinking are
another matter. Their solution lies not in
moralization, but in medical research, in
treatment, in prevention, in honest education
about how people function, and how alcohol
functions-what it can do and does do to
and for human beings."
This paragraph well expresses the theme
of this interesting, matter-of-fact book on
the age-old problem of alcoholism.
That excess drinking is an enormous problem is clearly demonstrated by the many recent statistics. The author points out, for
example., that out of sixty million consumers
of a.lcohol in the United States, there are
over three and one-half million excessive
drinkers, seven and one-half thousand of
whom are true alcoholics. These excessive
drinkers, through wage loss, accidents and
expenditures of p rivate and public welfare
agencies, cost the United States over one
billion dollars every year.
In his attack upon this problem, the author
believes that many of our present laws are
inadequate. Imprisonment and neglect, he
points out, are not substitutes for treatment.
The author offers many suggestions as to
what may be done about the welfare of the
alcoholic and about his rehabilitation.
Included in the book are excelle.n t chapters
on the history of alcohol ; the pharmacology
of alcohol ; the relation of alcohol to crime,
to accidents, to divorce and to venereal disease. One chapter is devoted to the organization and principles of Alcoholics Anonymous.

SOCIAL MEDIONE- ITS
DERIVATIONS AND OBJECTIVES
THE N EW YORK ACADEMY O F MEDICINE
INSTITUT E O F SOCIAL MEDICINE, 1947.
EDITED BY IAGO GALDSTON, M .D .

The Commonwettlth F11nd-New Y ork 1949,
294 pp.

This extremely interesting book is composed of an edited collection of papers given
before the In~ titute on Social Medicine
formed in connection with the Centennial
Celebrati on of the New York Academy of
Medicine in the spring of 1947. The papers
are printed in an orderly sequence and were
given by many eminent authori ties not only
in the fi eld of med icine, but also in the
field s of histo ry, philosophy, psychology,
p ~ychi a try, nutrition, economics, hygiene and
public health, sociology and anthropology.
Medicine as it is practised to-day still
tends to diagnose and treat an illness in an
individual, neglecting many of the factors
which may contribute to and help sustain
th e illness, such as economic and social conditions and many others. Although a great
mass of facts is already known about the
various aspects of environment which affect
man's well-being and happiness, these facts
are grouped into the separate fields named
above. It was the purpose of this symposium
to collect the opinions of various leaders in
many field s of study regarding the useful
knowledge wh ich their respective fields are
able to contribute towards a common pool of
knowledge about the health of mao, both as
an individual and as a society.
This having been done, it was also their
purpose to investigate means of integrating
130
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the isolated fields into one study - social
medicine - which would embrace the study
of all contribu tions to the health of man.
This is a positive study-to keep man happy
and healthy as well as to treat him when he
l,ccomes ill ; it embraces not only the ills of
the individual patient, but also those of society, which are many, as evidenced by the
frequency of wars, the wretched physical and
social condition of so many of its members,
and so on. The book continually stresses the
role that the medical practitioner should
play in social medicine. It is to be noted
that this is not a book about socialized medicine as seen in Great Britain to-day ; it is
about social medicine and the distinction between the two is adequately described.
Anyone connected with the field of medicine will find much of great value in this
relatively short book.
-DoUG. RICHARDsdN, '50

HALLMARKS OF MANKIND
FRBDBRIC WOOD }ONES

Bailliere, Tywtia/1 anti Cox, London, 86 pp.
The orthodox idea conce.r ning the development of man is that he is the highest developed member of the order Primates. That
is to say that the order Primates is made up
of a number of closely related animals that
represent an evolutionary sequence from
" lowest'" to '"highest," the lowest being represented by the Lemurs and the highest by
Man.
In this interesting little book, Wood Jones
presents considerable anatomical evide.nce to

show that this concept of man's development
may be entirely wrong.
As a result of his studies in comparative
anatomy Jones has come to the following
.:onclusions: at an extremely early period,
there existed a type of animal, perhaps unrecognizable as a monkey, which was destined to evolve into the Chimpanzee and
Gorilla (African monkeys), the Orangs and
Gibbons (Asiatic monkeys), and also Man.
Through various natural forces a line of
beasts, the Catarrini, developed. At a very
early period a branch was produced from
this main trunk which developed into Man.
Some time later, after considerable specialization and polishing of the main trunk, a
second branch was produced which became
the Gibbon and Gorilla. After still more
polishing and development the Chimpanzee
and Gorilla were produced.
It will be seen that if this be true, Man is
actually, in str:~cture, a far more primitive
beast than either Chimpanzee and Gorilla
or Gibbon and Orang. The Gorilla, according to Jones, is the apex of anthropoid development rather than man. The less an ape
has changed from its original form so much
more human he appears.
Although the evidence for these ideas are
not as yet completely convincing, they are
stimulating and add further weight to the
adage of Bacon, " that which the mind grasps
upon with esp ecial readiness is to be rega rd ed wtth suspicion."
An interesting book for those interested in
wandering along the byways of medical
science.
-R. PRINCE, '50

THE NATIONAL COMMITTEE FOR CHILE
is now receiving gifts for the library of the Medical School of the University of Chile at its new collection center in the Library of Congress,
Washington. The newer materials in the library, including periodicals,
books and reference materials, were totally destroyed in the recent fire.
Medical periodicals of the last ten years and recent medical books are
urgently needed. Your contribution will be appreciated.
National Committee for Ollie,
Room 318, Library of Congress; Washington, D.C.
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This is the first issue published by the 1949-50 staff of the Medical
Journal. As is apparent, many changes have been made in the journal.
These changes have been dictated by economic pressures which threaten
the very existence of the journal. However, in spite of the limitations
thus forced upon us we are striving to maintain a journal of high calibre
which will bring articles of general interest to all our readers.
The editors wish to welcome the reorganized Osler Society to the
Medical School scene. This society meets regularly to present papers on
medical history. W e feel that this is a very worthwhile study for medical
students and g raduates alike and we hope in the future to publish many
of the papers presented at these meetings. In this connection we note
with pleasure the appointment to the editorial board of the "Journal of
the History of Medicine and Allied Sciences" of Dr. Lloyd G . Stevenson.
Dr. Stevenson, a Western alumnus, is the author of "The Life of Sir
Frederick Banting." We will await with pleasure the appearance in our
journal of some of his articles on his return to Western.
Finally, we welcome at all times any suggestions from any of our
readers which will improve the Medical Journal.

